EZH2-shRNA-mediated upregulation of p21waf1/cip1 and its transcriptional enhancers with concomitant downmodulation of mutant p53 in pancreatic ductal adenocarcinoma

被引:5
作者
Batchu, Ramesh B. [1 ,2 ]
Qazi, Aamer M. [1 ,2 ]
Gruzdyn, Oksana V. [1 ,2 ]
Semaan, Assaad [1 ,3 ]
Seward, Shelly M. [1 ,3 ]
Chamala, Sreedhar [1 ,3 ]
Dhulipala, Vasu B. [1 ,2 ]
Bouwman, David L. [1 ]
Weaver, Donald W. [1 ]
Gruber, Scott A. [1 ,2 ]
机构
[1] Wayne State Univ, Lab Surg Oncol & Dev Therapeut, Dept Surg, Detroit, MI 48201 USA
[2] Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI 48201 USA
[3] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA
关键词
CANCER; EZH2; EXPRESSION; GROWTH; BREAST;
D O I
10.1016/j.surg.2013.06.041
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose. Enhancer of zeste homologue 2 (EZH2), a component of the chromatin modification protein complex, is upregulated in pancreatic ductal adenocarcinoma (PDAC), whereas loss of p53 and its downstream target, p21(waf1/cip1), is also observed frequently. We sought to investigate the role of the p53-p21(waf1/cip1) pathway in relation to EZH2-mediated inhibition of PDAC. Methods. The PANC-1 cell line was utilized in chromatin immunoprecipitation, gene profiling, Western blot, cell invasion, cell proliferation, and tumor xenograft assays. Results. Western blot analysis with antibodies that recognize both wild-type and mutant p53 did not show any alterations in band intensity; however, antibody that detects only mutant p53 showed a band of significantly lesser intensity with EZH2 knockdown. Western blot analysis further revealed a significant upregulation of p21(waf1/cip1). Gene expression profile analysis indicated significantly enhanced transcripts of transcriptional inducers of p21(waf1/cip1), with downregulation of mutant p53 transcript, corroborating the Western blot analysis. PANC-1 cells expressing EZH2-short hairpin RNA displayed markedly attenuated growth in SCID mice. Conclusion. Downregulation of mutant p53 with concomitant enhanced expression of p21(waf1/cip1) and its transcriptional trans-activators may contribute toward EZH2-mediated suppression of PDAC.
引用
收藏
页码:739 / 746
页数:8
相关论文
共 20 条
[1]   Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression [J].
Bao, Bin ;
Ali, Shadan ;
Banerjee, Sanjeev ;
Wang, Zhiwei ;
Logna, Farah ;
Azmi, Asfar S. ;
Kong, Dejuan ;
Ahmad, Aamir ;
Li, Yiwei ;
Padhye, Subhash ;
Sarkar, Fazlul H. .
CANCER RESEARCH, 2012, 72 (01) :335-345
[2]   The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells [J].
Bracken, Adrian P. ;
Kleine-Kohlbrecher, Daniela ;
Dietrich, Nikolaj ;
Pasini, Diego ;
Gargiulo, Gaetano ;
Beekman, Chantal ;
Theilgaard-Monch, Kim ;
Minucci, Saverio ;
Porse, Bo T. ;
Marine, Jean-Christophe ;
Hansen, Klaus H. ;
Helin, Kristian .
GENES & DEVELOPMENT, 2007, 21 (05) :525-530
[3]  
Chang C.J., 2011, BRIT J CANCER, V106, P243
[4]  
Chen YH, 2012, AM J TRANSL RES, V4, P364
[5]  
Crea F, 2012, CANCER METAST REV, P1
[6]  
ELDEIRY WS, 1994, CANCER RES, V54, P1169
[7]   The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2 [J].
Friedman, Jeffrey M. ;
Liang, Gangning ;
Liu, Chun-Chi ;
Wolff, Erika M. ;
Tsai, Yvonne C. ;
Ye, Wei ;
Zhou, Xianghong ;
Jones, Peter A. .
CANCER RESEARCH, 2009, 69 (06) :2623-2629
[8]   Molecular prognostic markers in pancreatic cancer: A systematic review [J].
Garcea, G ;
Neal, CP ;
Pattenden, CJ ;
Steward, WP ;
Berry, DP .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (15) :2213-2236
[9]   EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo [J].
Guo, Jianfeng ;
Cai, Jing ;
Yu, Lili ;
Tang, Huijuan ;
Chen, Chunyan ;
Wang, Zehua .
CANCER SCIENCE, 2011, 102 (03) :530-539
[10]  
HSIAO M, 1994, AM J PATHOL, V145, P702